Vadim V. Tarasov

2 ta ish

Sechenov University

1. Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines

   Eugenia D. Namiot, Aleksandr V. Sokolov, Vladimir N. Chubarev +2

   Sharh maqola20232 iqtibos

   ABIABI:AkademIndex/2026.other.475878

2. Rare diseases as a global priority: the CIS Orphan Forum and the path toward collaboration with BRICS

   Nuriya Z. Musina, Ahmed Al Saidi, Ayman W. El-Hattab +27

   MaqolaOAOchiq kirishGenomics and Rare DiseasesThe BRICS Health Journal20260 iqtibos

   ABIABI:AkademIndex/2026.article.014581